Screener
Emergent Biosolutions EBS Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on the most recent quarter.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's debt-to-equity?
- Emergent Biosolutions (EBS) reported debt-to-equity of 1.7× in Q2 2026.
- How has Emergent Biosolutions's debt-to-equity changed year-over-year?
- Emergent Biosolutions's debt-to-equity increased by 36.6% year-over-year, from 1.3× to 1.7×.
- What is the long-term trend for Emergent Biosolutions's debt-to-equity?
- Over 5 years (2020 to 2025), Emergent Biosolutions's debt-to-equity has grown at a 12.3% compound annual growth rate (CAGR), from 0.6× to 1.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Emergent Biosolutions's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude